Research study Program year 2025 Source: CMS Open Payments

Faricimab for Under Represented Patients With Dme

Research payments

$11,622,802

1,694 payments

Through program year 2025, $11,622,802 in research payments was reported against Faricimab for Under Represented Patients With Dme, across 1,694 payments.

Paid by (largest first): Genentech, Inc.; F. Hoffmann-La Roche AG
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$2,234,581	495
2024	Research	$3,398,502	474
2023	Research	$3,891,352	496
2022	Research	$2,098,367	229

Breakdown

Who paid Research payments · program years 2022–2025

Genentech, Inc. $11,602,145 1,678 payments
F. Hoffmann-La Roche AG $20,657 16 payments

Who received the money Research payments · program years 2022–2025

Charles Retina Institute Pc Organisation paid for research $1,047,184 123 payments
Emanuelli Research And Development Center LLC Organisation paid for research $1,035,645 107 payments
Brown Retina Institute Organisation paid for research $926,873 134 payments
Envision Ocular LLC Organisation paid for research $667,784 39 payments
University Retina & MacUla Associates Pc Organisation paid for research $533,102 44 payments
Eye Physicians Of Florida Organisation paid for research $525,357 40 payments
MD Medical Research Organisation paid for research $505,003 36 payments
Florida Retina Institute Organisation paid for research $446,423 28 payments
Sierra Eye Associates Organisation paid for research $428,563 106 payments
Emanuelli Research And Develop Organisation paid for research $359,445 17 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.